Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy

Dai, MG; Liu, SY; Lu, WF; Liang, L; Ye, B

Liang, L (通讯作者)，Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Gen Surg Canc Ctr,Dept Hepatobiliary & Pancreat Su, 158, Shangtang Rd, Hangzhou 310000, Zhejiang, Peoples R China.;Ye, B (通讯作者)，Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 5, 289, Kuocang Rd, Lishui 323000, Zhejiang, Peoples R China.

CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023; 17 ():

Abstract

Background:The long-term prognosis of patients with hepatocellular carcinoma (HCC) after surgery remains far from satisfactory, especially in patients......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索